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Andersen’s syndrome is caused by mutations in the
potassium channel Kir2.1, a major determinant of
resting membrane potential. The clinical features of this
disease illustrate the importance of a stable resting
membrane potential for many cell functions. 
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Clinical problems caused by disorders of membrane ion
channels are termed channelopathies. These disorders can
be of autoimmune (for example, myasthenia gravis), toxic
(for example, paralysis caused by snake venoms) or genetic
(for example, cystic fibrosis, long QT syndrome, familial
hemiplegic migraine) origin. Recently Plaster et al. [1]
reported a new channelopathy causing Andersen’s syn-
drome, a rare familial disease characterized by three key
clinical features — developmental defects in bony struc-
tures, periodic paralysis and cardiac arrhythmias. This group
demonstrated that the symptoms were caused by muta-
tions in the KCNJ2 gene, which encodes Kir2.1, an
α-subunit of a potassium channel involved in determining
and stabilizing the resting membrane potential in many
cell types. In order to understand the features of Ander-
sen’s syndrome, here we discuss the relationship between
cell function and resting membrane potential in the cell
systems involved.
The Kir family of potassium channel subunits
The Kir family of potassium channel subunits is large:
it consists of seven subfamilies each containing several
members (see [2] for a review). The Kir2 family members,
expressed in, for example, heart and nervous tissue, show
strong inward rectification, preferentially passing potas-
sium ions into the cell, and are involved in stabilizing the
resting membrane potential. Kir3 family members are
G-protein-activated potassium channels and, as an example,
they form the acetylcholine-sensitive potassium current of
heart cells. Kir6 family members, notably Kir6.2, form the
KATP channel of heart and pancreas.
The general topology of the Kir family members is depicted
in Figure 1. The Kir molecule consists of two α-helical
transmembrane segments (M1 and M2) separated by an
extracellular pore forming loop (H5 or P-loop) containing
the Gly–Tyr–Gly signature sequence that confers K+ selec-
tivity on ion channels. The amino and carboxyl termini are
located intracellularly. Four subunits form a channel and
recent evidence obtained with Kir6.2, an ATP-dependent
inward rectifier, suggests that the molecular structure of
Kir channels is comparable to that of KcsA, a bacterial
potassium channel [3].
Inward rectification and resting membrane potential
It has been known for more than fifty years that the resting
membrane potential of skeletal muscle fibers and heart
cells is mainly determined by a potassium conductance that
strongly rectifies in the inward direction, passing potassium
ions much more easily from the extracellular fluid into the
cytosol than vice versa. Later on, it was shown that inwardly
rectifying potassium channels are also involved in main-
taining the resting membrane potential in other cell types,
like smooth muscle cells, neurons and osteoclasts. 
Figure 2 shows the relationship between membrane voltage
and current flowing through these channels as can be
Figure 1
General topology of subunits of the Kir family of potassium channels.
Each subunit consists of two membrane-spanning α-helical segments
(M1 and M2) separated by the pore-forming domain P that contains the
amino acid sequence Gly-Tyr-Gly (GYG), which confers potassium
selectivity on the channel. The amino and carboxyl termini are located
intracellularly. Four subunits oligomerize to form a functional Kir
potassium channel.
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measured in voltage-clamp experiments. The current
reverses sign at the potassium equilibrium potential EK of
–95 mV, indicating that the channels are pure potassium
channels. At potentials positive to EK the channels pass a
small outward current (positive by convention) which
beyond –40 mV reduces to zero. Thus, when a cell depo-
larizes due to activation of inward currents (for example,
when a cardiac or skeletal muscle cell is stimulated to fire
an action potential), the channels completely close, thereby
preventing loss of potassium ions from the cytosol. Around
EK small hyperpolarizations will induce inward potassium
current flow and small depolarizations outward current
flow. Both will pull the membrane potential back to EK,
thus stabilizing the resting membrane potential. The actual
resting membrane potential will generally be more posi-
tive than EK because of other channels in the membrane
that pass current into the cytosol (such as background
sodium or calcium channels).
The strong inward rectification of Kir2 channels is caused
by binding of intracellular magnesium or organic cationic
polyamines like spermine and spermidine at potentials
positive to EK (see [4] for a review). The affinity of Kir2
channels for these cations appears to vary in different
organs or species, causing a somewhat variable shape of the
current–voltage relationship in the region positive to EK.
For instance, the region of negative slope conductance
between –80 and –40 mV, which is characteristic of the
inward rectifier of cardiac ventricular cells, IK1 (Figure 2),
is absent in cardiac atrial cells and skeletal muscle cells. In
the latter cells, the channel is virtually completely closed
at potentials positive to EK.
Resting membrane potential and Andersen’s syndrome
In the recent paper, Plaster et al. [1] report that families
and individuals diagnosed with Andersen’s syndrome, an
autosomal dominant disease, have mutations in KCNJ2, the
gene coding for Kir2.1. In all, they describe nine different
mutations affecting one or a few very conserved amino
acid residues across the Kir family. None of the mutations
was in the endoplasmic reticulum export signal and appar-
ently the mutated subunits are still translocated to the cell
membrane [5]. This finding is corroborated by electro-
physiological experiments: in oocytes expressing wild-type
Kir2.1, a distinct inward rectifier current was found; in
D71V mutation oocytes expressing an Asp71Val-mutated
form of Kir2.1, no current was measured; and in oocytes
expressing equivalent amounts of wild-type and mutant
Kir2.1, the inward rectifier current amplitude was about
6% of the wild-type control. This finding points to a strong
dominant-negative effect in which one mutated subunit
in a tetramer can completely suppress channel function.
Essentially the same observation was made with another
mutation (Arg218Trp), but in this case the remaining
current in the co-expressing cells was about 25% of control.
Whether the severity of the symptoms in Andersen’s syn-
drome (patients exhibiting one, two or all three clinical
features) is related to the intensity of the dominant-nega-
tive effect of the particular mutation, is as yet unknown. 
Many Andersen’s syndrome patients exhibit cardiac dys-
rhythmias reminiscent of LQT syndrome [6], ranging from
non-symptomatic prolongation of the QT interval to cardiac
arrest. The main determinant for LQT syndrome is pro-
nounced prolongation of the plateau phase of the action
potential. Figure 3 shows the effect of reducing IK1 to 6% of
control in a model of the human ventricular action potential
[7], mimicking the effects of the Asp71Val Kir2.1 mutant.
As expected, the resting membrane potential becomes
reduced and unstable (closer to activation threshold), which
by itself might be arrhythmogenic. Moreover, due to
altered activation and inactivation of voltage-dependent
inward and outward currents, the action potential is pro-
longed. So, theoretically, reduction of the inward rectifier
current might increase the propensity for arrhythmias. 
In practical terms, the situation seems to be more compli-
cated, however. Zaritsky et al. [8] investigated cardiac elec-
trical activity in mice lacking the Kir2.1 gene. In isolated
ventricular cells they found longer action potentials and
increased automaticity but no dramatic effect on resting
membrane potential. In intact animals they found a pro-
longed QT interval, but never an arrhythmia or even an
ectopic beat (see [9] for a possible explanation). Unexpect-
edly, they observed a severe bradycardia (from 390 to 240
beats per minute) which is as yet unexplained, and to the
best of our knowledge never observed in Andersen’s syn-
drome patients. 
Figure 2
Current–voltage relationship of the cardiac inward rectifier current (IK1)
as calculated from the Priebe–Beuckelmann model for electrical activity
of human ventricular cells [7]. Current density normalized to cell
capacitance is plotted against potential at which the membrane is
clamped for 200 msec from a holding potential of –70 mV.
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Periodic paralysis is another symptom associated with
Andersen’s syndrome. As in the heart, Kir2.1-built inward
rectifier channels in skeletal muscle are involved in stabiliz-
ing the resting membrane potential at a sufficiently negative
level to allow enough sodium channel availability for proper
activation of skeletal muscle contraction. When Kir2.1
expression is reduced, the resting membrane potential will
become less negative, hampering the removal of inactivation
of sodium channels. After some time, this will result in com-
plete inactivation of sodium channels, leading to paralysis.
During development, myoblasts fuse to myotubes, a process
that is essential for normal muscle formation and triggered
by calcium ions. Recently it was reported that Kir2.1-built
inward rectifier channels are necessary for this process [10]
because they bring the resting membrane potential to a
sufficiently negative level to allow the sustained inflow of
calcium ions through T-type calcium channels. Although
skeletal muscle abnormalities have not been reported in
Kir2.1-deficient mice or Andersen’s syndrome patients, it
is repeatedly mentioned that Andersen’s syndrome patients
are of ‘slender’ build, which might indicate mild impair-
ment of muscle development.
The third clinical sign of Andersen’s syndrome is impair-
ment of formation of bony structures, such as mild facial
abnormalities, scoliosis, abnormal placement of fingers,
and short stature. During bone development, blood vessels
arise prior to ossification and concomitantly osteoblasts
(bone-forming cells) and osteoclasts (bone-resorbing cells)
appear [11]. The final form of bones is determined by the
coordinated action of these cells amongst several other
mechanisms involved in collagen deposition.
Osteoclasts form a tightly closed compartment on the surface
of bone in which a low pH is maintained by the action of
an ATP-driven proton pump. At this low pH, mineral
components of bone become soluble and cathepsin-K
degrades collagen [12]. The withdrawal of H+ ions from
the cytoplasm of osteoclasts tends to hyperpolarize the
cells, counteracting further outflow of H+ ions. Kir2.1-built
inward rectifier channels are present in osteoclasts [13] and
allow the entrance of K+ ions into the cells in exchange for
H+ ions, thereby stabilizing the resting membrane poten-
tial and keeping the osteoclasts functioning. Mutations in
Kir2.1 reduce the amount of inward rectifier current and
might hamper the adequate functioning of osteoclasts,
thereby interfering with the balance between bone forma-
tion and resorption which might explain the mild dysmor-
phic symptoms in Andersen’s syndrome patients and the
much more severe deformity (complete cleft palate) in
Kir2.1-deficient mice [14] which is actually the cause of
perinatal lethality in these animals.
Conclusions
Andersen’s syndrome is a rare monogenetic disease that
beautifully illustrates the important role that inward recti-
fier channels play in maintaining the resting membrane
potential. It also impressively demonstrates that mainte-
nance of the resting membrane potential is not only impor-
tant for excitable cells in the classical sense but also for such
diverse mechanisms as bone resorption and skeletal muscle
formation. Many details of the exact pathways involved are
as yet unknown but undoubtedly the paper by Plaster et al.
[1] will instigate a renewed interest in the role of membrane
electrical phenomena in various cell functions.
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Figure 3
Simulated human ventricular action potentials
under control conditions (dashed line) and
upon reduction of IK1 to 6% (1/16) of control
(solid line). This is the amount of IK1 that
would remain if one mutated subunit would
completely suppress channel function by
dominant-negative effects because only one
out of 16 possible configurations consists of
four wild-type subunits. The model was
stimulated with 2 msec 20% suprathreshold
stimuli at a rate of 1 Hz.
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